The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 1, 2004, Pages 1-4

  Hassoun, Ziad ^a   Pomier Layrargues, Gilles ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Ascites; Cirrhosis; Portal hypertension; TIPS; Variceal bleeding

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTINEOPLASTIC AGENT; FUROSEMIDE; PLASMA SUBSTITUTE; SCLEROSING AGENT; SPIRONOLACTONE; VASOPRESSIN;

ARTIFICIAL VENTILATION; ASCITES; ASPIRATION PNEUMONIA; BUDD CHIARI SYNDROME; CLINICAL TRIAL; DEVASCULARIZATION; DOPPLER FLOWMETRY; DRUG EFFICACY; DUODENUM BLEEDING; GASTROINTESTINAL HEMORRHAGE; GENETIC ANALYSIS; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYDROTHORAX; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MORBIDITY; PARACENTESIS; PERITONEAL CAVITY; PORTAL HYPERTENSION; PORTOCAVAL SHUNT; PRESSURE GRADIENT; PRIORITY JOURNAL; RECURRENCE RISK; REFRACTORY VARICEAL BLEEDING; REVIEW; RISK REDUCTION; SEPSIS; SHUNTING; STATISTICAL SIGNIFICANCE; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; STOMACH VARICES; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTING; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN OCCLUSION; ESOPHAGUS VARICES; LIVER VEIN OBSTRUCTION; LIVER VEIN THROMBOSIS; METHODOLOGY; NOTE; PORTOSYSTEMIC ANASTOMOSIS;

ASCITES; ESOPHAGEAL AND GASTRIC VARICES; HEPATIC VEIN THROMBOSIS; HEPATIC VENO-OCCLUSIVE DISEASE; HEPATORENAL SYNDROME; HUMANS; HYDROTHORAX; HYPERTENSION, PORTAL; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 3042743466     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200401000-00001     Document Type: Review

References (44)

1. Richter GM, Palmaz JC, Noldge G, Rossle M, Siegerstetter V, Franke M, et al. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe 1989; 29:406-411.
2. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-852.
3. Burroughs AK. Assessment of value of consensus definitions in acute variceal bleeding. Lancet 2001; 357:1147-1148.
4. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
5. de Franchis R, Primignani M. Endoscopic treatments for portal hypertension. Semin Liver Dis 1999; 19:439-455.
6. Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic sclerotherapy versus portacaval shunt in patient with severe cirrhosis and acute variceal hemorrhage. Long-term follow-up. N Engl J Med 1987; 316:11-15.
7. McCormick PA, Kaye GL, Greenslade L, Cardin F, Hobbs KE, McIntyre N, et al. Esophageal staple transection as a salvage procedure after failure of acute injection sclerotherapy. Hepatology 1992; 15:403-406.
8. Willson PD, Kunkler R, Blair SD, Reynolds KW. Emergency oesophageal transection for uncontrolled variceal haemorrhage. Br J Surg 1994; 81:992-995.
9. Jalan R, John TG, Redhead DN, Garden OJ, Simpson KJ, Finlayson ND, et al. A comparative study of emergency transjugular intrahepatic portosystemic stent-shunt and esophageal transection in the management of uncontrolled variceal hemorrhage. Am J Gastroenterol 1995; 90:1932-1937.
10. Luca A, D'Amico G, La Galla R, Midiri M, Morabito A, Pagliaro L. TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials. Radiology 1999; 212:411-421.
11. Papatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: a meta-analysis. Hepatology 1999; 30:612-622.
12. Burroughs AK, Patch D. Transjugular intrahepatic portosystemic shunt. Semin Liver Dis 1999; 19:457-473.
13. Barange K, Peron JM, Imani K, Otal P, Payen JL, Rousseau H, et al. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices. Hepatology 1999; 30: 1139-1143.
14. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. 'Salvage' transjugular intrahepatic portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-987.
15. Sanyal AJ, Freedman AM, Luketic VA, Purdum PP, Shiffman ML, Tisnado J, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111:138-146.
16. Patch D, Nikolopoulou V, McCormick A, Dick R, Armonis A, Wannamethee G, et al. Factors related to early mortality after transjugular intrahepatic portosystemic shunt for failed endoscopic therapy in acute variceal bleeding. J Hepatol 1998; 28:454-460.
17. Azoulay D, Castaing D, Majno P, Saliba F, Ichai P, Smail A, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 2001; 35:590-597.
18. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-663.
19. Pomier-Layrargues G, Villeneuve JP, Gesehenes M, Bui B, Perreault P, Fenyves D, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001; 48: 390-396.
20. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002; 35:385-392.
21. Norton ID, Andrews JC, Kamath PS. Management of ectopic varices. Hepatology 1998; 28:1154-1158.
22. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23:164-176.
23. Pomier-Layrargues G, Hassoun Z. Treatment of refractory ascites using the TIPS procedure. In: Schein M, Wiese L (editors): Controversies in Surgery, vol. 4. Berlin: Springer Verlag; 2001, pp. 205-208.
24. Lebrec D, Giuily N, Hadengue A, Vilgrain V, Moreau R, Poynard T, et al. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists. J Hepatol 1996; 25:135-144.
25. Rossle M, Ochs A, Gulberg V, Siegerstetter V, Holl J, Deibert P, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000; 342:1701-1707.
26. Gines P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123:1839-1847.
27. Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology 2003; 124:634-641.
28. Deschenes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol 1999; 84:1361-1365.
29. Thuluvath PJ, Bal JS, Mitchell S, Lund G, Venbrux A. TIPS for management of refractory ascites: response and survival are both unpredictable. Dig Dis Sci 2003; 48:542-550.
30. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25:1366-1369.
31. Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transpl Surg 1998; 4: 416-423.
32. Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum HE, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol 2001; 13:529-534.
33. Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000; 47:288-295.
34. Perello A, Garcia-Pagan JC, Gilabert R, Suarez Y, Moitinho E, Cervantes F, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35:132-139.
35. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118: 905-911.
36. Spahr L, Villeneuve JP, Dufresne MP, Tasse D, Bui B, Willems B, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44:739-742.
37. Chalasani N, Clark WS, Martin LG, Kamean J, Khan MA, Patel NH, et al. Determinants of mortality in patients with advanced cirrhosis after transjugular intrahepatic portosystemic shunting. Gastroenterology 2000; 118:138-144.
38. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-871.
39. Salerno F, Merli M, Cazzaniga M, Valeriano V, Rossi P, Lovaria A, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002; 36:494-500.
40. Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003; 52:879-885.
41. Cejna M, Peck-Radosavljevic M, Thurnher SA, Hittmair K, Schoder M, Lammer J. Creation of transjugular intrahepatic portosystemic shunts with stent-grafts: initial experiences with a polytetrafluoroethylene-covered nitinol endoprosthesis. Radiology 2001; 221:437-446.
42. Bureau C, Garcia-Pagan JC, Pomier-Layrargues G, Otal P, Chabbert V, Cortez C, et al. The use of polytetrafluoroethylene (PTFE) covered stents improves the patency of TIPS: results of a randomized study [Abstract]. Hepatology 2002; 36:294A.
43. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Semin Liver Dis 1996; 16:315-320.
44. Hassoun Z, Deschenes M, Lafortune M, Dufresne MP, Perreault P, Lepanto L, et al. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy. Am J Gastroenterol 2001; 96:1205-1209.